Alessandro Rolfo

Prof. Alessandro Rolfo

Department of Surgical Sciences, University of Turin, Turin, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Alessandro RolfoAlessandro Rolfo
Alessandro Rolfo
Anna Maria NuzzoAnna Maria Nuzzo
Anna Maria Nuzzo
Ramona De AmicisRamona De Amicis
Ramona De Amicis
LAURA MORETTILAURA MORETTI
LAURA MORETTI
SBSimona Bertoli
Simona Bertoli
ALAlessandro Leone
Alessandro Leone
Endocrine-disrupting chemicals (EDCs) are exogenous substances able to mimic or to interfere with the endocrine system, thus altering key biological processes such as organ development, reproduction, immunity, metabolism and behavior. High concentrations of EDCs are found in several everyday products including plastic bottles and food containers and they could be easily absorbed by dietary intake. In recent years, considerable interest has been raised regarding the biological effects of EDCs, particularly Bisphenol A (BPA) and phthalates, on human pregnancy and fetal development. Several evidence obtained on in vitro and animal models as well as by epidemiologic and population studies strongly indicated that endocrine disruptors could negatively impact fetal and placental health by interfering with the embryonic developing epigenome, thus establishing disease paths into adulthood. Moreover, EDCs could cause and/or contribute to the onset of severe gestational conditions as Preeclampsia (PE), Fetal Growth Restriction (FGR) and gestational diabetes in pregnancy, as well as obesity, diabetes and cardiovascular complications in reproductive age. Therefore, despite contrasting data being present in the literature, endocrine disruptors must be considered as a therapeutic target. Future actions aimed at reducing or eliminating EDC exposure during the perinatal period are mandatory to guarantee pregnancy success and preserve fetal and adult health.

1 January 2013 in Kidney International
Verified
Journal Article
Closed access
Alessandro RolfoAlessandro Rolfo
Alessandro Rolfo
RARossella Attini
Rossella Attini
Anna Maria NuzzoAnna Maria Nuzzo
Anna Maria Nuzzo
APAnnalisa Piazzese
Annalisa Piazzese
SPSilvia Parisi
Silvia Parisi
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli

1 June 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
SZStacy Zamudio
Stacy Zamudio
YWYuanhong Wu
Yuanhong Wu
FIFrancesca Ietta
Francesca Ietta
Alessandro RolfoAlessandro Rolfo
Alessandro Rolfo
ACAshley Cross
Ashley Cross
ICIsabella Caniggia
Isabella Caniggia

12 October 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Alessandro RolfoAlessandro Rolfo
Alessandro Rolfo
AMAriel Many
Ariel Many
ARAntonella Racano
Antonella Racano
RTReshef Tal
Reshef Tal
ATAndrea Tagliaferro
Andrea Tagliaferro
ICIsabella Caniggia
Isabella Caniggia
The pathogenesis of preeclampsia, a serious pregnancy disorder, is still elusive and its treatment empirical. Hypoxia Inducible Factor-1 (HIF-1) is crucial for placental development and early detection of aberrant regulatory mechanisms of HIF-1 could impact on the diagnosis and management of preeclampsia. HIF-1α stability is controlled by O2-sensing enzymes including prolyl hydroxylases (PHDs), Factor Inhibiting HIF (FIH), and E3 ligases Seven In Absentia Homologues (SIAHs). Here we investigated early- (E-PE) and late-onset (L-PE) human preeclamptic placentae and their ability to sense changes in oxygen tension occurring during normal placental development. Expression of PHD2, FIH and SIAHs were significantly down-regulated in E-PE compared to control and L-PE placentae, while HIF-1α levels were increased. PHD3 expression was increased due to decreased FIH levels as demonstrated by siRNA FIH knockdown experiments in trophoblastic JEG-3 cells. E-PE tissues had markedly diminished HIF-1α hydroxylation at proline residues 402 and 564 as assessed with monoclonal antibodies raised against hydroxylated HIF-1α P402 or P564, suggesting regulation by PHD2 and not PHD3. Culturing villous explants under varying oxygen tensions revealed that E-PE, but not L-PE, placentae were unable to regulate HIF-1α levels because PHD2, FIH and SIAHs did not sense a hypoxic environment. Disruption of oxygen sensing in E-PE vs. L-PE and control placentae is the first molecular evidence of the existence of two distinct preeclamptic diseases and the unique molecular O2-sensing signature of E-PE placentae may be of diagnostic value when assessing high risk pregnancies and their severity.

1 January 2008 in The American Journal of Pathology
Verified
Journal Article
Closed access
YYYoav Yinon
Yoav Yinon
ONOri Nevo
Ori Nevo
JXJing Xu
Jing Xu
AMAriel Many
Ariel Many
Alessandro RolfoAlessandro Rolfo
Alessandro Rolfo
ICIsabella Caniggia
Isabella Caniggia

1 August 2009 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RCRoberta Cavalli
Roberta Cavalli
ABAgnese Bisazza
Agnese Bisazza
Alessandro RolfoAlessandro Rolfo
Alessandro Rolfo
SBSonia Balbis
Sonia Balbis
DMDaniele Madonnaripa
Daniele Madonnaripa
CGCaterina Guiot
Caterina Guiot